AAAAAA
Results: 1-25/36
Authors:
MALTEZOU HC
PETROPOULOS D
GARDNER M
ABISAID D
MANTZOURANIS EC
ROLSTON KVI
CHAN KW
Citation: Hc. Maltezou et al., VARICELLA-ZOSTER VIRUS-INFECTION IN CHILDREN WITH HEMATOPOIETIC STEM-CELL TRANSPLANTS, International journal of pediatric hematology/oncology, 5(5), 1998, pp. 345-351
Authors:
WITHERSPOON RP
MCGLAVE P
CAMPBELL JB
ROLSTON KVI
Citation: Rp. Witherspoon et al., WEIGHT-LOSS, SKIN RASH, AND COUGH FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Cancer practice, 6(4), 1998, pp. 202-205
Authors:
ROLSTON KVI
Citation: Kvi. Rolston, COMMENTARY - CHEMOPROPHYLAXIS AND BACTERIAL-RESISTANCE IN NEUTROPENICPATIENTS, Infectious diseases in clinical practice, 7(4), 1998, pp. 202-204
Authors:
ROLSTON KVI
MANZULLO E
ELTING L
FRISBEEHUME S
RODRIGUEZ S
RUBENSTEIN EB
Citation: Kvi. Rolston et al., AMBULATORY MANAGEMENT OF VARICELLA-ZOSTER VIRUS-INFECTION IN IMMUNOCOMPROMISED CANCER-PATIENTS, Supportive care in cancer, 6(1), 1998, pp. 57-62
Authors:
ROLSTON KVI
Citation: Kvi. Rolston, RISK ASSESSMENT AND RISK-BASED THERAPY IN FEBRILE NEUTROPENIC PATIENTS, European journal of clinical microbiology & infectious diseases, 17(7), 1998, pp. 461-463
Authors:
RAAD II
HACHEM RY
ABISAID D
ROLSTON KVI
WHIMBEY E
BUZAID AC
LEGHA S
Citation: Ii. Raad et al., A PROSPECTIVE CROSSOVER RANDOMIZED TRIAL OF NOVOBIOCIN AND RIFAMPIN PROPHYLAXIS FOR THE PREVENTION OF INTRAVASCULAR CATHETER INFECTIONS IN CANCER-PATIENTS TREATED WITH INTERLEUKIN-2, Cancer, 82(2), 1998, pp. 403-411
Authors:
HUGHES WT
ARMSTRONG D
BODEY GP
BROWN AE
EDWARDS JE
FELD R
PIZZO P
ROLSTON KVI
SHENEP JL
YOUNG LS
Citation: Wt. Hughes et al., 1997 GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER, Clinical infectious diseases, 25(3), 1997, pp. 551-573
Authors:
ELTING LS
RUBENSTEIN EB
ROLSTON KVI
BODEY GP
Citation: Ls. Elting et al., OUTCOMES OF BACTEREMIA IN PATIENTS WITH CANCER AND NEUTROPENIA - OBSERVATIONS FROM 2 DECADES OF EPIDEMIOLOGIC AND CLINICAL-TRIALS, Clinical infectious diseases, 25(2), 1997, pp. 247-259
Authors:
SUNDARARAJAN V
RUBENSTEIN EB
ROLSTON KVI
ELTING LS
Citation: V. Sundararajan et al., CONTROVERSIES IN NEW ANTIBIOTIC-THERAPY FOR AMBULATORY PATIENTS, Supportive care in cancer, 5(5), 1997, pp. 358-364
Authors:
ROLSTON KVI
RODRIGUEZ S
DHOLAKIA N
WHIMBEY E
RAAD I
Citation: Kvi. Rolston et al., PULMONARY INFECTIONS MIMICKING CANCER - A RETROSPECTIVE, 3-YEAR REVIEW, Supportive care in cancer, 5(2), 1997, pp. 90-93
Authors:
ESCALANTE CP
RUBENSTEIN EB
ROLSTON KVI
Citation: Cp. Escalante et al., OUTPATIENT ANTIBIOTIC-THERAPY FOR FEBRILE EPISODES IN LOW-RISK NEUTROPENIC PATIENTS WITH CANCER, Cancer investigation, 15(3), 1997, pp. 237-242
Authors:
ROLSTON KVI
HO DH
LEBLANC B
STREETER H
DVORAK T
Citation: Kvi. Rolston et al., IN-VITRO ACTIVITY OF TROVAFLOXACIN AGAINST CLINICAL BACTERIAL ISOLATES FROM PATIENTS WITH CANCER, Journal of antimicrobial chemotherapy, 39, 1997, pp. 15-22
Authors:
MALTEZOU HC
PETROPOULOS D
CHOROSZY M
GARDNER M
MANTZOURANIS EC
ROLSTON KVI
CHAN KW
Citation: Hc. Maltezou et al., DAPSONE FOR PNEUMOCYSTIS-CARINII PROPHYLAXIS IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(10), 1997, pp. 879-881
Authors:
HACHEM R
RAAD I
ROLSTON KVI
WHIMBEY E
KATZ R
TARRAND J
LIBSHITZ H
Citation: R. Hachem et al., CUTANEOUS AND PULMONARY INFECTIONS CAUSED BY MYCOBACTERIUM-VACCAE, Clinical infectious diseases, 23(1), 1996, pp. 173-175
Authors:
ROLSTON KVI
Citation: Kvi. Rolston, FUNGAL-INFECTIONS IN IMMUNOSUPPRESSED CANCER-PATIENTS, Medical microbiology letters, 5(6), 1996, pp. 315-318
Authors:
ROLSTON KVI
Citation: Kvi. Rolston, OUTPATIENT MANAGEMENT OF FEVER IN NEUTROPENIC PATIENTS, Current opinion in infectious diseases, 9(6), 1996, pp. 407-410
Authors:
ESCALANTE CP
RUBENSTEIN EB
ROLSTON KVI
Citation: Cp. Escalante et al., OUTPATIENT ANTIBIOTIC-TREATMENT IN LOW-RISK FEBRILE NEUTROPENIC CANCER-PATIENTS, Supportive care in cancer, 4(5), 1996, pp. 358-363
Authors:
ROLSTON KVI
RUBENSTEIN EB
FREIFELD A
Citation: Kvi. Rolston et al., EARLY EMPIRIC ANTIBIOTIC-THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW-RISK, Infectious disease clinics of North America, 10(2), 1996, pp. 223
Authors:
ROLSTON KVI
DHOLAKIA N
HO DH
LEBLANC B
DVORAK T
STREETER H
Citation: Kvi. Rolston et al., IN-VITRO ACTIVITY OF RAMOPLANIN (A NOVEL LIPOGLYCOPEPTIDE), VANCOMYCIN, AND TEICOPLANIN AGAINST GRAM-POSITIVE CLINICAL ISOLATES FROM CANCER-PATIENTS, Journal of antimicrobial chemotherapy, 38(2), 1996, pp. 265-269
Authors:
ROLSTON KVI
ELTING L
WAGUESPACK S
LEBLANC B
BODEY GP
Citation: Kvi. Rolston et al., SURVEY OF ANTIBIOTIC SUSCEPTIBILITY AMONG GRAM-NEGATIVE BACILLI AT A CANCER CENTER, Chemotherapy, 42(5), 1996, pp. 348-353
Authors:
RAAD II
WHIMBEY EE
ROLSTON KVI
ABISAID D
HACHEM RY
PANDYA RG
GHADDAR HM
KARL CL
BODEY GP
Citation: Ii. Raad et al., A COMPARISON OF AZTREONAM PLUS VANCOMYCIN AND IMIPENEM PLUS VANCOMYCIN AS INITIAL THERAPY FOR FEBRILE NEUTROPENIC CANCER-PATIENTS, Cancer, 77(7), 1996, pp. 1386-1394
Authors:
RUBENSTEIN EB
ROLSTON KVI
Citation: Eb. Rubenstein et Kvi. Rolston, OUTPATIENT TREATMENT OF FEBRILE NEUTROPENIC PATIENTS WITH CANCER, European journal of cancer, 31A(1), 1995, pp. 2-4
Authors:
ROLSTON KVI
DHOLAKIA N
RODRIGUEZ S
RUBENSTEIN EB
Citation: Kvi. Rolston et al., NATURE AND OUTCOME OF FEBRILE EPISODES IN PATIENTS WITH PANCREATIC AND HEPATOBILIARY CANCER, Supportive care in cancer, 3(6), 1995, pp. 414-417
Authors:
RUBENSTEIN EB
FENDER A
ROLSTON KVI
ELTING LS
PRASCO P
PALMER J
RAAD I
POLLOCK RE
FRISBEEHUME S
LAURENCE D
HOHN DC
Citation: Eb. Rubenstein et al., VASCULAR ACCESS BY PHYSICIAN ASSISTANTS - EVALUATION OF AN IMPLANTABLE PERIPHERAL PORT SYSTEM IN CANCER-PATIENTS, Journal of clinical oncology, 13(6), 1995, pp. 1513-1519
Authors:
ROLSTON KVI
RUBENSTEIN EB
Citation: Kvi. Rolston et Eb. Rubenstein, ACUTE-RENAL-FAILURE ATTRIBUTABLE TO CIPROFLOXACIN IN A PATIENT WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - REPLY, Archives of internal medicine, 155(1), 1995, pp. 114-115